Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 4, 2012, Pages 305-311

  Chiesa, Alberto ^a   Crisafulli, Concetta ^b   Porcelli, Stefano ^a   Han, Changsu ^c   Patkar, Ashwin A ^d   Lee, Soo Jung ^e   Park, Moon Ho ^c   Jun, Tae Youn ^f   Serretti, Alessandro ^a   Pae, Chi Un ^d,e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Korea University College of Medicine   (South Korea)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e The Catholic University of Korea   (South Korea)

^f The Catholic University of Korea   (South Korea)

Author keywords

GRIA1; GRIA2; GRIA4; Major depressive disorder

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; GRIA1 GENE; GRIA2 GENE; GRIA4 GENE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; AGE OF ONSET; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, AMPA; REPUBLIC OF KOREA; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 84864927226     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0270-y     Document Type: Article

References (28)

1. Danysz W, Parsons CG (1998) Glycine and n-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664 (Pubitemid 29028813)
2. Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW (2008) An innovative design to establish proof of concept of the antidepressant effects of the nr2b subunit selective n-methyld- aspartate antagonist, cp-101, 606, in patients with treatmentrefractory major depressive disorder. J Clin Psychopharmacol 28:631-637
3. Martins-de-Souza D, Harris LW, Guest PC, Turck CW, Bahn S (2010) The role of proteomics in depression research. Eur Arch Psychiatry Clin Neurosci 260:499-506
4. Wang X, Li YH, Li MH, Lu J, Zhao JG, Sun XJ, Zhang B, Ye JL (2011) Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-011-0209-3
5. Schmitt A, Hasan A, Gruber O, Falkai P (2011) Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-011-0242-2
6. Nakanishi N, Shneider NA, Axel R (1990) A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 5:569-581
7. Wenthold RJ, Yokotani N, Doi K, Wada K (1992) Immunochemical characterization of the non-nmda glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain. J Biol Chem 267:501-507
8. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS (1996) Evidence for multiple ampa receptor complexes in hippocampal ca1/ca2 neurons. J Neurosci 16:1982-1989 (Pubitemid 26144011)
9. Hollmann M, Hartley M, Heinemann S (1991) Ca2? permeability of ka-ampa-gated glutamate receptor channels depends on subunit composition. Science 252:851-853 (Pubitemid 121000528)
10. Bleakman D, Alt A, Witkin JM (2007) Ampa receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets 6:117-126 (Pubitemid 46681772)
11. Martinez-Turrillas R, Del Rio J, Frechilla D (2005) Sequential changes in bdnf mrna expression and synaptic levels of ampa receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49:1178-1188 (Pubitemid 41608642)
12. Palucha A, Pilc A (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115:116-147 (Pubitemid 46992810)
13. Schmitt WB, Sprengel R, Mack V, Draft RW, Seeburg PH, Deacon RM, Rawlins JN, Bannerman DM (2005) Restoration of spatial working memory by genetic rescue of glur-a-deficient mice. Nat Neurosci 8:270-272 (Pubitemid 40300181)
14. Black MD (2005) Therapeutic potential of positive ampa modulators and their relationship to ampa receptor subunits. A review of preclinical data. Psychopharmacology (Berl) 179:154-163 (Pubitemid 40584805)
15. Ekholm JM, Kieseppa T, Hiekkalinna T, Partonen T, Paunio T, Perola M, Ekelund J, Lonnqvist J, Pekkarinen-Ijas P, Peltonen L (2003) Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 12:1907-1915 (Pubitemid 36944144)
16. McInnis MG, Lan TH, Willour VL, McMahon FJ, Simpson SG, Addington AM, MacKinnon DF, Potash JB, Mahoney AT, Chellis J, Huo Y, Swift-Scanlan T, Chen H, Koskela R, Stine OC, Jamison KR, Holmans P, Folstein SE, Ranade K, Friddle C, Botstein D, Marr T, Beaty TH, Zandi P, DePaulo JR (2003) Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry 8:288-298 (Pubitemid 36712922)
17. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, Juvonen H, Kokko-Sahin ML, Vaisanen L, Mannila H, Lonnqvist J, Peltonen L (1999) A genomewide screen for schizophrenia genes in an isolated finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 65:1114-1124 (Pubitemid 30462969)
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The miniinternational neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59(Suppl 20):22-33 (quiz 34-57) (Pubitemid 29001829)
19. Serretti A, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Pae CU (2011) Influence of tph2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Res 189:26-32
20. Montgomery SM (1979) Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol 3:429-433 (Pubitemid 10158397)
21. Riedel M, Moller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, Kronmuller K, Nickel T, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Seemuller F (2010) Response and remission criteria in major depression-a validation of current practice. J Psychiatr Res 44:1063-1068
22. StatSoft (1995) Statistica per windows. StatSoft Italia srl
23. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of ld and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
24. Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, pp 8-14
25. Zubenko GS, Zubenko WN, Spiker DG, Giles DE, Kaplan BB (2001) Malignancy of recurrent, early-onset major depression: a family study. Am J Med Genet 105:690-699 (Pubitemid 33101468)
26. Kerner B, Jasinska AJ, DeYoung J, Almonte M, Choi OW, Freimer NB (2009) Polymorphisms in the gria1 gene region in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 150B:24-32
27. Sullivan PF (2007) Spurious genetic associations. Biol Psychiatry 61:1121-1126 (Pubitemid 46669468)
28. Zimmerman M, Mattia JI, Posternak MA (2002) Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 159:469-473 (Pubitemid 34184745)